ElizabethMarieMobleyMD

Urology • Austin, TX

Female Urology/Pelvic Medicine & Reconstructive Surgery, Minimally Invasive Surgery, Stone Disease

President, Urology Austin Urologist

Join to view full profile

Dr. Mobley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mobley's full profile

Already have an account?

Office
11410 Jollyville Rd
Suite 1101
Austin, TX 78759
Phone+1 512-231-1444

Fax+1 512-231-1470

Education & Training

University of Utah HealthResidency, Urology, 2009 - 2013
University of Utah HealthInternship, Transitional Year, 2008 - 2009
Medical College of Georgia at Augusta UniversityClass of 2008

Certifications & Licensure

TX State Medical License 2015 - 2026
UT State Medical License 2009 - 2026
American Board of Urology Urology

Awards, Honors, & Recognition

Axonics Center of Excellence Axonics, 2023-2024
Urolift Center of Excellence Teleflex Interventional Urology, 2019-2024

Clinical Trials

A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy Start of enrollment: 2020 Dec 18
Recruiting
Phase 2
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) Start of enrollment: 2023 Mar 23
Recruiting
Phase 3
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) Start of enrollment: 2024 Apr 09
Recruiting
Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer Start of enrollment: 2024 Apr 18
Recruiting
Phase 3
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH Start of enrollment: 2021 Dec 06
Recruiting
Phase 4
Comparing UroLift Experience Against Rezūm Start of enrollment: 2021 Jan 22
Recruiting
Not Applicable
Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients. Start of enrollment: 2018 Oct 23
Recruiting
Not Applicable
ProVee Urethral Expander System IDE Study (ProVIDE) Start of enrollment: 2022 Jun 09
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

24 citations
Update on plication procedures for Peyronie's disease and other penile deformities.
Elizabeth M. Mobley, Molly E. Fuchs, Jeremy B. Myers, William O. Brant
Therapeutic Advances in Urology. 2012-06-25